Skip to main content

Giulio Superti-Furga´s group discovered a key component of the nutrients sensing machinery of cells

In order to decide whether to grow and proliferate or to break down and recycle, cells need to sense if the required nutrients are available. A central role in this context is played by the mechanistic target of rapamycin (mTOR) pathway that integrates the presence of growth factors, energy levels, glucose and amino acids to modulate cellular responses, such as protein and lipid synthesis. Past studies have demonstrated that the presence of amino acids is a crucial factor for mTOR activation. Despite this, the precise mechanisms by which amino acid levels are sensed are still poorly understood. In collaboration with Keiryn Bennetts group at…

Read more

Launch of Genom Austria

In a press conference on November 25th, 'Genom Austria' was announced as a joint Citizen Science Project of CeMM, the Medical University of Vienna, and the foundation. Genom Austria will explore the scientific, educational, philosophical, ethical, and social implications of personal genome sequencing. Following the model of Harvard’s Personal Genome Project, Genom Austria provides qualifying volunteers the opportunity to sequence their personal genomes and to share the data with the public. An important aim is to start a public debate on the opportunities and risks associated with whole genome information and contribute to…

Read more

How influenza virus causes bacterial superinfection

Viruses can predispose the host to bacterial superinfection, and secondary pneumonia is considered to play a major role in the morbidity of seasonal as well as pandemic influenza. Despite the significant clinical and socioeconomic impact, the molecular mechanisms of how influenza virus causes superinfection have been poorly understood. Scientists from Andreas Bergthaler´s Group at CeMM now succeeded in finding a new molecular mechanism, which may explain why influenza virus infections increase the susceptibility to bacterial pneumonia. Their discovery of a novel crosstalk between the antiviral molecule interferon and the enzyme Setdb2, which…

Read more

Human Proteome Day

As a follow-up to the publications on the initial draft of the human proteome that appeared in Nature in May this year, Bernhard Küster and Akhilesh Pandey were invited to CeMM to present their key research findings. As part of their presentations, the speakers described the broad range of applications of their research, such as the use of protein identification to aid forensic teams at crime scenes, or a large-scale malarial study in India. They also discussed the future of this research field, including the aim to produce a more refined map of the human proteome and also the development of proteogenomic centers to complement upcoming…

Read more

Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity

The team of Kaan Boztug, Principal Investigator at CeMM and Assistant Professor at the Department of Pediatrics and Adolescent Medicine of the Medical University of Vienna discovered the molecular origin of a new rare disease and succeeded in deciphering the essential role of the NFkB-inducing kinase (NIK) for an efficient immune response in humans. The findings have been published online, on November 19th, 2014, in the open access journal Nature Communications. 

Primary immunodeficiencies are inherited disorders resulting in malfunction of the immune system. The identification of the molecular defects underlying these disorders is crucial…

Read more
Max L. Birnstiel 2007 in Vienna with his scientific son and grandson Meinrad Busslinger and Giulio Superti-Furga

Obituary Max L. Birnstiel

It is with great sadness that we learn of the decease of Prof. Dr. h.c. mult. Max L. Birnstiel, of Wollerau, Switzerland. Max Birnstiel was the founding director of the Institute of Molecular Pathology (IMP) in Vienna and can be held responsible for kicking off the renaissance of the life sciences in Austria in the last 25 years. As a mentor of the CeMM director Giulio Superti-Furga, who in the late eighties had followed him as a PhD student together with his PhD supervisor Meinrad Busslinger, from Zurich to Vienna, Max Birnstiel provided important advice for the making and leadership of CeMM. Max Birnstiel will long remain a towering figure…

Read more

10 Year Anniversary of the MedUni Vienna

It is our great pleasure to congratulate the Medical University of Vienna on their 10 year anniversary! The Medical University of Vienna is one of our key research partners and plays a major role in the education and scientific development of CeMM’s PhD students, and postdoctoral fellows. We truly value the strong collaborative relationship with our neighbours, and we would like to thank the rectorate, our collaborators and the administrative staff of the Medical University of Vienna for their cooperation. Several members of CeMM Faculty are also affiliated with the Medical University and thus represent a successful “marriage” of ideas and…

Read more

4th Vienna Next Generation Sequencing Symposium & Workshop at CeMM

The 4th Vienna Next Generation Sequencing Symposium & Workshop brought together over 150 current and future users of next generation sequencing technology. Six invited speakers described exciting applications of NGS technology in basic biology and in biomedical research. And the keynote speaker Bart Deplancke (École Polytechnique Fédérale de Lausanne, EPFL) presented a biologically interesting and methodologically advanced study on the massive-scale characterization of the genome regulatory code in Drosophila. The meeting was organized by Christoph Bock (Coordinator of the BSF Biomedical Sequencing Facility of CeMM and MedUni Vienna) and…

Read more

Giulio Superti-Furga and Kilian Huber at CeMM Win GlaxoSmithKline’s European Discovery Fast Track Challenge to Investigate a New Anti-Cancer Drug Targeting MTH1

Giulio Superti-Furga, Scientific Director and Kilian Huber, Senior Postdoctoral Fellow at CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, have been selected as winners of GlaxoSmithKline plc’s (GSK) 2014 European Discovery Fast Track Challenge, which is designed to accelerate the translation of academic research into novel therapies. CeMM will partner with scientists in GSK’s Discovery Partnerships with Academia (DPAc) and Molecular Discovery Research (MDR) teams to screen the target against GSK’s compound collection. Active compounds could then form the basis of full drug discovery programmes that may…

Read more

CeMM Scientific Director Giulio Superti-Furga elected member of the Academia Europaea

CeMM Scientific Director Giulio Superti-Furga was recently elected member of the Academia Europaea – the Academy of Europe. The election followed a recommendation of the Academic Sections and a peer review by the Nominations Committee of the academy.

The Academia Europaea is a registered not-for-profit charity founded in 1988 as an international, nongovernmental association of eminent, individual scientists and scholars from across the continent of Europe who are experts and leaders in their own subject areas as recognized by their peers. Currently 3000 academy members span the full range of academic disciplines comprising the humanities,…

Read more